Tampe Désirée, Tampe Björn
Department of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.
J Clin Med. 2022 Jun 19;11(12):3526. doi: 10.3390/jcm11123526.
We have previously reported that the ultrasound (US)-guided tip positioning is an accurate and safe procedure for placement of retrograde- and antegrade-tunneled hemodialysis catheters (HDCs). However, determinants of tunneled hemodialysis catheter implantation time by using US guidance have not been described yet. Therefore, we here report a comparative analysis to identify determinants of implantation time for retrograde- and antegrade-tunneled HDCs placement by US guidance.
We performed a cross-sectional study to compare implantation time for US-guided tip positioning of retrograde- and antegrade-tunneled HDCs. We included a total number of 47 tunneled HDC insertions, including 23 retrograde tunneled and 24 antegrade-tunneled HDCs in patients requiring placement of an HDC for the temporary or permanent treatment of end-stage kidney disease (ESKD) in a single-center, cross-sectional pilot study.
We show that clinical and laboratory parameters did not differ between retrograde- and antegrade-tunneled HDC implantations. There was a tendency for shorter implantation time in antegrade-tunneled HDCs, although not statistically significant. Finally, we identified an independent inverse association between body weight (BW) and platelet counts with HDC implantation time specifically in antegrade-tunneled HDCs.
In this study, we identified determinants for tunneled HDC implantation time that might be relevant for patients and interventionists.
我们之前报道过，超声（US）引导下的尖端定位是一种准确且安全的逆行和顺行隧道式血液透析导管（HDC）置入方法。然而，关于使用超声引导进行隧道式血液透析导管植入时间的决定因素尚未见描述。因此，我们在此报告一项比较分析，以确定超声引导下逆行和顺行隧道式HDC置入植入时间的决定因素。
我们进行了一项横断面研究，比较超声引导下逆行和顺行隧道式HDC尖端定位的植入时间。在一项单中心横断面试点研究中，我们纳入了总共47例隧道式HDC插入病例，其中包括23例逆行隧道式和24例顺行隧道式HDC，这些患者因终末期肾病（ESKD）的临时或永久治疗而需要置入HDC。
我们发现逆行和顺行隧道式HDC植入之间的临床和实验室参数没有差异。顺行隧道式HDC的植入时间有缩短的趋势，尽管没有统计学意义。最后，我们确定体重（BW）和血小板计数与HDC植入时间之间存在独立的负相关，特别是在顺行隧道式HDC中。
在本研究中，我们确定了隧道式HDC植入时间可能与患者和干预者相关的决定因素。
